[1]
Abdoh, Q., Kittaneh, A., Rabi, R., Dweikat, A., Darwish, A., Najajra, D., Awwad, M., Rajab, I., Yaghmour, R. and Alnees, M. 2024. Risk factors for anti-infliximab antibody formation among patients with inflammatory bowel disease. MedNEXT Journal of Medical and Health Sciences. 5, 3 (Jul. 2024). DOI:https://doi.org/10.54448/mdnt24305.